Search for: "Natco, Inc." Results 21 - 40 of 63
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Apr 2014, 3:51 pm by Lyle Denniston
The generic firms — Sandoz Inc., Momenta Pharmaceuticals, Inc., Mylan Pharmaceuticals, Inc., and Natco Pharma Ltd. [read post]
13 Feb 2014, 9:04 am
According to this decision, Bayer must license Nexavar to Natco Pharma, an Indian company, in exchange for a 6% royalty on Natco's net sales. [read post]
3 Apr 2013, 4:45 am by Eric Guttag
Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. for patent infringement in the [...]... [read post]
31 Dec 2012, 11:41 pm by Shouvik Kumar Guha
’s Zoll unit has filed a suit against Royal Philips Electronics’ Respironics Inc. before the US District Court of Delaware, alleging infringement of a U.S. patent with equipment used to monitor patients being treated for sleep-disordered breathing. [read post]
30 Nov 2012, 6:00 am by Gene Quinn
Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. for patent infringement in the [...]... [read post]
30 Nov 2012, 6:00 am by Gene Quinn
Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. for patent infringement in the [...]... [read post]
11 Sep 2012, 5:30 am by Gene Quinn
Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. for patent infringement in the [...]... [read post]
1 Jun 2012, 1:58 pm by Gene Quinn
Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. for patent infringement in the [...]... [read post]
6 Nov 2011, 9:18 pm by Patent Docs
Breckenridge Pharmaceutical Inc. et al. 1:11-cv-01070; filed November 2, 2011 in the District Court of Delaware • Plaintiffs: Cephalon Inc.; Cephalon France • Defendants: Breckenridge Pharmaceutical Inc.; Natco Pharma Ltd. [read post]
7 Sep 2011, 4:22 am by Marie Louise
  Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog)   Please join the… [read post]
30 Aug 2011, 5:18 am by Lawrence B. Ebert
Teva, the world's largest generic drug company, won a court battle in SDNY in its role as a proprietary drug company making Copaxone, against Novartis AG's Sandoz unit, Momenta Pharmaceuticals Inc., Mylan Inc., and Natco Pharma Ltd. [read post]
23 May 2011, 7:57 am by Kara OBrien
To date, the SEC has publicly announced only one prior example of such a cooperation tool–its December 20, 2010, NPA with Carter’s Inc. [read post]
22 Mar 2011, 4:21 pm by Marie Louise
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly…  well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
15 Feb 2011, 5:26 pm by Marie Louise
(FDA Law Blog) Diovan (Vasartan) – France: Novartis v Actavis – preliminary injunction for Valsartan confirmed (The SPC Blog) Diovan HTC (Valsartan) – Belgium: Antwerp Court of Appeal stops infringement of Valsartan/HCTZ SPC based on patent claiming Valsartan alone: Novartis v Teva (The SPC Blog) Lescol (Fluvastatin) – US: Novartis files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) (GenericsWeb) Mucinex (Guaifenesin) – US: Watson… [read post]
31 Aug 2010, 10:01 pm by Kelly
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
21 Jul 2010, 1:05 am by Kelly
Lupin Pharmaceuticals, Inc (FDA Law Blog) Olux (Clobetasol) – Perrigo confirms patent challenge for Colobetasol propionate emulsion foam (GenericsWeb) Prandin (Repaglinide) – US: Actavis, Sandoz bring inequitable conduct counterclaims against Novo Nordisk in Prandin suit (Patent Docs) Protonix (Pantoprazole) – US: District Court New Jersey denies Teva’s motion to overturn jury verdict finding the patent in suit not invalid in Protonix litigation (SmartBrief)… [read post]